Virmedex Launches Dex: The First Perfusion AI Chatbot
Virmedex, an emerging innovator in medical simulation training, has announced the introduction of Dex, the first All-things Perfusion AI Chatbot. This groundbreaking development marks a significant advancement in training technology, demonstrating Virmedex’s commitment to revolutionizing the field of healthcare education worldwide.
“We are thrilled to introduce Dex to our users,” says Dr. Martí de Castro, AI Chief of Virmedex. Dex will be available to all Virmedex platform users at no additional cost, providing invaluable assistance with complex perfusion-related calculations, board exam preparation, theoretical concepts, and more. For those interested in using Dex exclusively, it will be available for a nominal fee. “The launch of our Dex represents a significant milestone for our company, marking the successful integration of cutting-edge technology as a cornerstone of our operations. This advancement has the potential to contribute significantly to perfusion in the medical industry” concludes Dr. de Castro. Read more…
More news
Virmedex: When Video Games Save Lives in the Operating Room
Specialist portal Aware.Doctor analyzes Virmedex's brand identity, 3D design language, and its educational philosophy of building resilience through controlled mistakes in virtual environments.
Read the article →
Virmedex Awarded the City of Barcelona Prize for Applied Innovation
Academic and public media celebrate Virmedex receiving the City of Barcelona Prize for its outstanding achievements in applied technological innovation within the healthcare sector.
Read the article →
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
Virmedex announces the growth of its software subscriptions in European hospitals and US universities, moving forward with strategic preparations to open a second funding round in mid-2026.
Read the article →